Bertil Uggla
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Cancer-related Molecular Pathways
- Drug Transport and Resistance Mechanisms
Papers in
- Hematology 20
- Acute Myeloid Leukemia Research 13
- Hematopoietic Stem Cell Transplantation 4
-
- Hematological disorders and diagnostics 3
- Co-authors
- Gunnar Juliusson (13 shared papers)Sören Lehmann (12 shared papers)Ulf Tidefelt (7 shared papers)Christer Paul (5 shared papers)Martin Höglund (14 shared papers)Per‐Ola Andersson (6 shared papers)Lars Möllgård (13 shared papers)Vladimir Lazarević (12 shared papers)
In The Last Decade
Bertil Uggla
33 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 59
- Hematology 658
- Oncology 290
- Pathology and Forensic Medicine 134
- Emergency Medicine 40
- Genetics 39
Countries citing papers authored by Bertil Uggla
This map shows the geographic impact of Bertil Uggla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertil Uggla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertil Uggla more than expected).
Fields of papers citing papers by Bertil Uggla
This network shows the impact of papers produced by Bertil Uggla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertil Uggla. The network helps show where Bertil Uggla may publish in the future.
Co-authors
The 25 scholars most cited alongside Bertil Uggla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 352 | |
| 2 | 2014 | 227 | |
| 3 | 2014 | 137 | |
| 4 | 2004 | 89 | |
| 5 | 2017 | 72 | |
| 6 | 2011 | 68 | |
| 7 | Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes. | 2006 | 60 |
| 8 | 2014 | 50 | |
| 9 | 2017 | 49 | |
| 10 | 2016 | 33 | |
| 11 | 2018 | 19 | |
| 12 | 2022 | 19 | |
| 13 | 2015 | 18 | |
| 14 | CRIM1 is expressed at higher levels in drug-resistant than in drug-sensitive myeloid leukemia HL60 cells. | 2010 | 15 |
| 15 | Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells. | 2009 | 14 |
| 16 | 2017 | 14 | |
| 17 | 2021 | 14 | |
| 18 | 2014 | 13 | |
| 19 | 2014 | 13 | |
| 20 | 2019 | 13 |
About Bertil Uggla
Bertil Uggla is a scholar working on Hematology, Emergency Medicine, Genetics, Oncology and Genetics, having authored 34 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (13 papers), Hematopoietic Stem Cell Transplantation (4 papers), Blood disorders and treatments (3 papers), Hematological disorders and diagnostics (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Cancer therapeutics and mechanisms (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Pneumonia and Respiratory Infections (2 papers). The work is most often cited by research in Hematology (658 citations), Oncology (290 citations), Pathology and Forensic Medicine (134 citations), Emergency Medicine (40 citations) and Genetics (39 citations). Bertil Uggla has collaborated with scholars based in Sweden, Norway and Finland. Frequent co-authors include Gunnar Juliusson, Sören Lehmann, Ulf Tidefelt, Christer Paul, Martin Höglund, Per‐Ola Andersson, Lars Möllgård, Vladimir Lazarević, Åsa Rangert Derolf and Lovisa Wennström. Their work appears in journals such as European Journal Of Haematology, Blood, Leukemia Research, Haematologica and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.